Immunoglobulin M Levels Inversely Correlate With CD40 Ligand Promoter Methylation in Patients With Primary Biliary Cirrhosis
Ana Lleò(Humanitas University), Eric M. Gershwin(National Institute of Neurological Disorders and Stroke), Gaetana Lanzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Ming Zhao(Central South University), Le Ma(Central South University), Pietro Invernizzi(Azienda Ospedaliera San Gerardo), Qianjin Lu(Central South University), Peng Zhang(Central South University), Zhiguang Zhou(Central South University), Yijun Li(Harvard University), Francesca Bernuzzi(Humanitas University), Aftab A. Ansari(University of Science and Technology, Meghalaya), Jieyue Liao(Central South University), Ross L. Coppel(Australian Regenerative Medicine Institute)
Cited by 132
Related Papers
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k